Maki Yoshino

723 total citations
32 papers, 411 citations indexed

About

Maki Yoshino is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Physiology. According to data from OpenAlex, Maki Yoshino has authored 32 papers receiving a total of 411 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Nephrology, 10 papers in Pulmonary and Respiratory Medicine and 5 papers in Physiology. Recurrent topics in Maki Yoshino's work include Dialysis and Renal Disease Management (9 papers), Renal cell carcinoma treatment (5 papers) and Renal Diseases and Glomerulopathies (5 papers). Maki Yoshino is often cited by papers focused on Dialysis and Renal Disease Management (9 papers), Renal cell carcinoma treatment (5 papers) and Renal Diseases and Glomerulopathies (5 papers). Maki Yoshino collaborates with scholars based in Japan, United States and Italy. Maki Yoshino's co-authors include Tomonari Okada, Yume Nagaoka, Toshiyuki Nakao, Hiroshi Matsumoto, Nathan W. Levin, Abhijit V. Kshirsagar, Ronald G. Craig, James D. Beck, Steven Offenbacher and Julie Yip and has published in prestigious journals such as SHILAP Revista de lepidopterología, Kidney International and American Journal of Kidney Diseases.

In The Last Decade

Maki Yoshino

28 papers receiving 386 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maki Yoshino Japan 10 150 115 98 75 65 32 411
Jeffrey M. Curtis United States 11 199 1.3× 45 0.4× 92 0.9× 93 1.2× 24 0.4× 15 457
Robert Steelman United States 10 37 0.2× 9 0.1× 51 0.5× 21 0.3× 16 0.2× 40 359
David Cherney Canada 8 77 0.5× 79 0.7× 83 0.8× 18 0.2× 2 0.0× 28 378
H. Nasrat Saudi Arabia 12 7 0.0× 46 0.4× 94 1.0× 45 0.6× 3 0.0× 21 429
Jun Gyo Gwon South Korea 10 19 0.1× 9 0.1× 41 0.4× 44 0.6× 3 0.0× 54 335
Arun Jose United States 8 5 0.0× 14 0.1× 22 0.2× 21 0.3× 3 0.0× 36 272
José Augusto Sisson de Castro Brazil 10 3 0.0× 16 0.1× 89 0.9× 50 0.7× 6 0.1× 13 432
A. Torrijos Spain 11 3 0.0× 25 0.2× 40 0.4× 27 0.4× 3 0.0× 17 453
Haneol S. Jeong United States 9 11 0.1× 55 0.5× 15 0.2× 13 0.2× 12 263
Geetanjali Agarwal India 10 15 0.1× 50 0.4× 6 0.1× 17 0.2× 22 327

Countries citing papers authored by Maki Yoshino

Since Specialization
Citations

This map shows the geographic impact of Maki Yoshino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maki Yoshino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maki Yoshino more than expected).

Fields of papers citing papers by Maki Yoshino

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maki Yoshino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maki Yoshino. The network helps show where Maki Yoshino may publish in the future.

Co-authorship network of co-authors of Maki Yoshino

This figure shows the co-authorship network connecting the top 25 collaborators of Maki Yoshino. A scholar is included among the top collaborators of Maki Yoshino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maki Yoshino. Maki Yoshino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mizuno, Toshihisa, Haruka Ito, Maki Yoshino, et al.. (2025). Safety of Enfortumab Vedotin Plus Pembrolizumab in Hemodialysis Patients With Metastatic Urothelial Carcinoma: Case Report. Cancer Diagnosis & Prognosis. 5(5). 647–651.
2.
3.
Shirai, Yoko, Kenichiro Miura, Mari Suzuki, et al.. (2024). Partial bladder transplantation with en bloc kidney transplant—long-term, 17 years, the outcome of a “bladder patch technique”. American Journal of Transplantation. 24(11). 2121–2124. 1 indexed citations
4.
Omae, Kenji, Tsunenori Kondo, Shingo Fukuma, et al.. (2023). Effects of remote ischemic preconditioning on renal protection in patients undergoing robot-assisted laparoscopic partial nephrectomy. Journal of Robotic Surgery. 17(5). 2081–2087.
5.
Yamashita, Kaori, et al.. (2022). Urinary Tract Infection in Hemodialysis-Dependent End-Stage Renal Disease Patients. SHILAP Revista de lepidopterología. 1 indexed citations
6.
Yoshino, Maki, Hiroki Ishihara, Kazutaka Nakamura, et al.. (2022). Therapeutic role of deferred cytoreductive nephrectomy in patients with metastatic renal cell carcinoma treated with nivolumab plus ipilimumab. Japanese Journal of Clinical Oncology. 52(10). 1208–1214. 12 indexed citations
7.
Tachibana, Hidekazu, Tsunenori Kondo, Maki Yoshino, et al.. (2021). New Longitudinal Component of the RENAL Nephrometry Score for Predicting the Operative Complexity in Transperitoneal Robot-Assisted Partial Nephrectomy. Journal of Endourology. 36(6). 762–769. 4 indexed citations
8.
Nishida, Keiichiro, Keita Utsunomiya, Shinpei Nonen, et al.. (2015). Neuropsychological Evaluation and Cerebral Blood Flow Effects of Apolipoprotein E4 in Alzheimer's Disease Patients after One Year of Treatment: An Exploratory Study. SHILAP Revista de lepidopterología. 5(3). 414–423. 5 indexed citations
9.
Yamamoto, Kazumi, Kenji Kanbara, Tetsuya Abe, et al.. (2010). Psychological characteristics of Japanese patients with chronic pain assessed by the Rorschach test. BioPsychoSocial Medicine. 4(1). 20–20. 5 indexed citations
10.
Kshirsagar, Abhijit V., Ronald G. Craig, Kevin Moss, et al.. (2009). Periodontal disease adversely affects the survival of patients with end-stage renal disease. Kidney International. 75(7). 746–751. 109 indexed citations
11.
Matsumoto, Hiroshi, Tomonari Okada, Yume Nagaoka, et al.. (2008). A simple method of evaluating endogenous insulin secretory function during hemodialysis session. Nihon Toseki Igakkai Zasshi. 41(3). 187–193. 1 indexed citations
12.
13.
Kshirsagar, Abhijit V., Ronald G. Craig, James D. Beck, et al.. (2007). Severe Periodontitis Is Associated with Low Serum Albumin among Patients on Maintenance Hemodialysis Therapy. Clinical Journal of the American Society of Nephrology. 2(2). 239–244. 58 indexed citations
14.
Wada, Toshikazu, Yume Nagaoka, Hiroshi Matsumoto, et al.. (2006). [A pregnant woman with nephrotic syndrome and focal segmental lesions].. PubMed. 48(7). 680–4. 2 indexed citations
15.
Kuhlmann, Martin K., Maki Yoshino, & Nathan W. Levin. (2004). Differences in cardiovascular mortality rates among hemodialysis patients in the United States and Japan: The importance of background cardiovascular mortality. Hemodialysis International. 8(4). 394–399. 8 indexed citations
16.
Okada, Tomonari, Hiroshi Matsumoto, Maki Yoshino, et al.. (2003). [Henoch-Schönlein purpura nephritis in a patient infected with the human immunodeficiency virus].. PubMed. 45(4). 387–92. 8 indexed citations
17.
Nakao, Toshiyuki, et al.. (2003). Nutritional management of dialysis patients: Balancing among nutrient intake, dialysis dose, and nutritional status. American Journal of Kidney Diseases. 41(3). S133–S136. 14 indexed citations
18.
Okada, Tomonari, Toshiyuki Nakao, Hiroshi Matsumoto, et al.. (2003). Longitudinal changes in dialysate CA125 levels in peritoneal dialysis patients. Nihon Toseki Igakkai Zasshi. 36(10). 1545–1552. 1 indexed citations
19.
Nakagawa, Kazuhiko, et al.. (2002). Plasma concentrations of atrial and brain natriuretic peptides in a case with hypertensive encephalopathy. Neurological Research. 24(6). 627–632. 5 indexed citations
20.
Nakao, Toshiyuki, Maki Yoshino, Hiroshi Matsumoto, et al.. (1999). Low-density lipoprotein apheresis retards the progression of hyperlipidemic overt diabetic nephropathy. Kidney International. 56. S206–S209. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jeffrey M. Curtis Breakdown of academic impact, for papers by Robert Steelman Breakdown of academic impact, for papers by David Cherney Breakdown of academic impact, for papers by H. Nasrat Breakdown of academic impact, for papers by Jun Gyo Gwon Breakdown of academic impact, for papers by Arun Jose Breakdown of academic impact, for papers by José Augusto Sisson de Castro Breakdown of academic impact, for papers by A. Torrijos Breakdown of academic impact, for papers by Haneol S. Jeong Breakdown of academic impact, for papers by Geetanjali Agarwal
Rankless by CCL
2026